Freedom of information (FOI) releases from MHRA

This is a disclosure log of Medicines and Healthcare products Regulatory Agency's responses to freedom of information (FOI) or environmental information regulations (EIR) requests that might be of wider public interest.

If you can't find the information you're looking for, you can make a new FOI request.

Filters

Clear filters

  • Keywords filters

  • Year filters

  • Month filters

745 disclosures

  1. The MHRA and CHM pertaining CHM decision to expand the NiQuitin indication (Type II variation)

    On Wed 5, Dec 2024 Perrigo received correspondence from the MHRA to inform us that the agency and the independent experts in CHM will be reviewing the decision to expand the NiQuitin indication (Type II variation) that was approved on 17-10-2024, based on the evidence that was presented. We have been advised that this referral is necessary because it is not completely aligned with the previous decision made by the CHM some time ago. We request that all information which is held by the MHRA and CHM pertaining to this previous CHM decision is shared.

    Published: 28 March 2025

  2. Data on dietary supplements and online sales

    I am writing to request information under the Freedom of Information Act regarding the regulation of dietary supplements sold online, including those on Amazon and other third-party websites. Specifically, I would like to know: - What measures are in place to monitor the safety and efficacy of dietary supplements sold through online platforms? - How many investigations or actions have been taken against supplement manufacturers for misleading claims or ingredient discrepancies related to products sold on Amazon or similar sites? - Can you provide data on any recalls of dietary supplements in the last five years, particularly those linked to online sales? - Are you able to provide a breakdown of the most commonly reported dietary supplements that have raised safety concerns or complaints?

    Published: 28 March 2025

  3. 5 News

    I am writing to request information under the Freedom of Information Act regarding illegal prescription drug sales in the UK. Specifically, I would like to know: How many reports of illegal prescription drug sales have been received in the past five years? What types of prescription drugs are most commonly reported as being sold illegally? Can you provide data on enforcement actions taken against individuals or groups selling prescription medications without authorisation? Are there any specific trends noted in the methods used to sell these drugs, such as social media platforms?

    Published: 28 March 2025

  4. Freedom of Information request - Updates to Interactive Drug Analysis Profiles

    On your website people are able to access DAP reports on the alleged side-effects associated with drugs. Currently the data on there is up to and including reports processed relating to 19th May. Could you inform me what of what information you hold on when the publicly searchable DAP reports will be updated throughout 2025 and on those dates when it is updated what proposed date of information will the database be brought up to? So for example your answer might be that on 31st March the database will be updated to inlcude all data up to and including reports from the 31st December 2024.

    Published: 28 March 2025

  5. Documents relating to VPAG and debranding

    We write to request: • all documentation including email correspondence, memoranda or notes; • relating to the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG); • sent or received between the MHRA and the Department of Health and Social Care (DHSC); • authored after 1 January 2024; • containing the search terms "unbranded", "debranded", "authorised generic".

    Published: 28 March 2025

  6. Marketing Authorisation application made by Northwest Biotherapeutics

    I am enquiring about the Marketing Authorisation application made by Northwest Biotherapeutics on December 21,2023. If possible, could you please answer the following questions: 1. Was the Marketing application for this company received and if so when? 2. Is this application still being processed on the MHRA's rapid 150 day review pathway? 3. Has a decision be made for this application or is it currently still pending under review?

    Published: 28 March 2025

  7. Request for Information - Enterprise Application

    You may have received the same request in the past and this information sent has now expired and I require an update as soon as possible for the following. The information I require relates to the organisation’s software contract, please send me the organisation’s primary contract around the types of contracts below. I require the organisations to provide me with the following contract information relating to the following corporate software/enterprise applications: A. Enterprise Resource Planning Software Solution (ERP) -this is the organisation’s main ERP system and may include service support, maintenance and upgrades. B. Primary Customer Relationship Management (CRM) Solution-this is the organisation’s main CRM system and may include service support, maintenance and upgrades. Example of CRM systems the organisation may use could include Microsoft Dynamics, Front Office, Lagan CRM, Firm step C. Primary Human Resources (HR) and Payroll Software Solution-this is the organisation’s main HR/payroll system and may include service support, maintenance and upgrades. In some cases, the HR contract maybe separate to the payroll contract please provide both types of contracts. Example of HR/Payroll systems the organisation may use could include iTrent, Resource link. D. The organisation’s primary corporate Finance Software Solution-this is the organisation’s main Finance system and may include service support, maintenance and upgrades. Example of finance systems the organisation may use could include E-Business suite, Agresso (Unit4), eFinancials, Integra, SAP In some cases you may come across contracts that provides service support maintenance and upgrades separate to the main software contract, please also provide this information in the response following the requested data below. For each of the categories above can you please provide me with the relevant contract information listed below: 1. Software Category: ERP, CRM, HR, Payroll, Finance 2. Name of Supplier: Can you please provide me with the software provider for each contract? 3. The date in which these applications were implemented 4. The brand of the software: Can you please provide me with the actual name of the software. Please do not provide me with the supplier’s name again please provide me with the actual software name. 5. Description of the contract: Please do not just state two to three words can you please provide me with detailed information about this contract and please state if upgrade, maintenance and support is included. Please also include any modules included within the contract as this will support the categories you have selected in question 1. 6. Number of Users/Licenses: What is the total number of user/licenses for this contract? 7. Annual Spend: What is the annual average spend for each contract? 8. Contract Duration: What is the duration of the contract please include any available extensions within the contract. 9. Contract Start Date: What is the start date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY. 10. Contract Expiry: What is the expiry date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY. 11. Contract Review Date: What is the review date of this contract? Please include month and year of the contract. If this cannot be provided, please provide me estimates of when the contract is likely to be reviewed. DD-MM-YY or MM-YY. 12. Contact Details: I require the full contact details of the person within the organisation responsible for this particular software contract (name, job title, email, contact number). If any of the information is not available, please can you provide me with the notes on the reasons why?

    Published: 28 March 2025

  8. How many UK patients are currently prescribed dopamine agonists for Restless Legs Syndrome

    I want to know the number of UK patients currently prescribed Ropinirole Pramipexole Rotigitone(Neupro) Carbidopa Levodopa For Restless Legs Syndrome.

    Published: 28 March 2025

  9. Faxed letter to Dept of Health 21st Dec 1990

    I am writing to you to make a freedom of information request, regarding the attached letter from yourselves to Dr Jeremy Metters at the Department of Health dated 21st Dec 1990. 1. Could you please provide a copy of the data from your preliminary findings. 2. Could you please advise if any further research took place following this letter of 21st Dec 1990, advising DOH of your preliminary findings? 3. If so, please provide a copy of the further research data.

    Published: 28 March 2025

  10. Environmental risk assessment for Haldol Injection

    I kindly wish to request under the FOI Act the approved environmental risk assessment for Haldol Injection (PL 00242/0036R). We understand this marketing authorisation is now withdrawn in the UK, however please can you provide the ERA which was current at the time of withdrawal.

    Published: 28 March 2025